Study protocol: Cost effectiveness of two strategies to implement the NVOG guidelines on hypertension in pregnancy: An innovative strategy including a computerised decision support system compared to a common strategy of professional audit and feedback, a randomized controlled trial

Implementation Science

Volumn 5, Issue 1, 2010, Pages

  Luitjes, Susanne H E ^a,b   Wouters, Maurice G A J ^a   Franx, Arie ^c   Scheepers, Hubertina C J ^d   Coupé, Veerle M H ^a   Wollersheim, Huub ^e   Steegers, Eric A P ^f   Heringa, Martijn P ^g   Hermens, Rosella P M G ^e   van Tulder, Maurits W ^b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c CPRLab   (Netherlands)

^d MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^e RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^f ERASMUS MEDICAL CENTER   (Netherlands)

^g UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77956461218     PISSN: None     EISSN: 17485908     Source Type: Journal    
DOI: 10.1186/1748-5908-5-68     Document Type: Article

References (25)

1. Sibai BM, Caritis SN, Thom E, Klebanoff M, McNellis D, Rocco L, Paul RH, Romero R, Witter F, Rosen M, Depp R. Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med 1993, 329:1213-8. 10.1056/NEJM199310213291701, 8413387.
2. Perry IJ, Beevers DG. The definition of pre-eclampsia. Br J Obstet Gynaecol 1994, 101:587-91.
3. Levine RJ, Hauth JC, Curet LB, Sibai BM, Catalano PM, Morris CD, DerSimonian R, Esterlitz JR, Raymond EG, Bild DE, Clemens JD, Cutler JA. Trail of calcium to prevent preeclampsia. N Engl J Med 1997, 337:69-76. 10.1056/NEJM199707103370201, 9211675.
4. Golding J, . The Jamaica Low Dose Aspirin Study Group A randomised trial of low dose aspirin for primiparae in pregnancy. Br J Obstet Gynaecol 1998, 105:293-9. The Jamaica Low Dose Aspirin Study Group.
5. Odegard RA, Vatten LJ, Nilsen ST, Salvesen KA, Austgulen R. Risk factors and clinical manifestations of pre-eclampsia. Br J Obstet Gynaecol 2000, 107:1410-6.
6. Subtil D, Goeusse P, Puech F, Lequin P, Biausque S, Breart G, Uzan S, Marquis P, Parmentier D, Churlet A. Aspirin (100 mg) used for prevention of pre-eclampsia in nulliparous women: the Essai Regional Aspirine Mere-Enfant study (Part 1). Br J Obstet Gynaecol 2003, 110:475-84.
7. Ganzevoort W, Rep A, Bonsel GJ, Fetter WPF, van Sonderen L, de Vries JIP, Wolf H. A randomised controlled trial comparing two temporising management strategies, one with and one without plasma volume expansion, for severe and early-onset pre-eclampsia. BJOG 2005, 112:1358-68. 10.1111/j.1471-0528.2005.00687.x, 16167938.
8. Ganzevoort W, Rep A, de Vries JIP, Bonsel GJ, Wolf H. Prediction of maternal complications and adverse infant outcome at admission for temporizing management of early-onset severe hypertensive disorders of pregnancy. Am J Obstet Gynecol 2006, 195:495-503. 10.1016/j.ajog.2006.02.012, 16643825.
9. Schutte JM. Safe pregnancy in the Netherlands. NTOG 2010, 123:27-28.
10. Schuitemaker NWE, van Roosmalen J, Dekker G, van Dongen P, van Geijn HP, Bennebroek Gravenhorst J. Confidential enquiry into maternal deaths in The Netherlands 1983-1992. Eur J Obstet Gynecol Reprod Biol 1998, 79:57-62. 10.1016/S0301-2115(98)00053-0, 9643405.
11. Why Mothers Die 2000-2002. The Confidential Enqueries into Maternal Deaths in the United Kingdom. 2004, London: RCOG Press.
12. Briët JW, Steegers EA, Visser W, de Boer K, Pel M, Santema JG. Maternal mortality caused by preeclampsia in The Netherlands: a reason for concern. Ned Tijdschr Obstet Gynaecol 2005, 118:132-5.
13. Schutte JM, de Boer K, Briet JW. Maternal mortality in The Netherlands: the tip of the iceberg. Ned Tijdschr Obstet Gynaecol 2005, 118:89-91.
14. Schutte JM, Schuitemaker NWE, van Roosmalen J, Steegers EA, . Dutch Maternal Mortality Committee Substandard care in maternal mortality due to hypertensive disease in pregnancy in the Netherlands. BJOG 2008, 115(6):732-6. 10.1111/j.1471-0528.2008.01702.x, 18410657, Dutch Maternal Mortality Committee.
15. Guideline Hypertensive Disorders in Pregnancy. 2005, Utrecht: The Dutch Society of Obstetrics and Gynaecology.
16. Guideline Chronic Hypertension in Pregnancy. 2005, Utrecht: The Dutch Society of Obstetrics and Gynaecology.
17. Grol R, Grimshaw J. From best evidence to best practice: effective implementation of change in patients'care. Lancet 2003, 362:1225-30. 10.1016/S0140-6736(03)14546-1, 14568747.
18. Chaudhry B, Wang J, Wu S, Maglione M, Mojica W, Roth E, Morton SC, Shelleke PG. Systematic review: impact of health information technology on quality, efficiency, and costs of medical care. Ann Int Med 2006, 144:742-52.
19. Grol R, Wensing M. Implementatie: effectieve verbetering van de patiëntenzorg. 2006, Maarssen: Elsevier Gezondheidszorg.
20. Cantrill JA, Sibbald B, Buetow S. Indicators of the appropriateness of long-term prescribing in general practice in the United Kingdom: consensus development, face and content validity, feasibility, and reliability. Qual Health Care 1998, 7:130-5. 10.1136/qshc.7.3.130, 2483608, 10185138.
21. Campbell SM, Cantrill JA, Roberts D. Prescribing indicators for UK general practice: Delphi consultation study. BMJ 2000, 321:1-5. 10.1136/bmj.321.7252.1, 1127674, 10875807.
22. van Roosmalen J, Schuitemaker NW, Brand R, van Dongen PW, Bennebroek Gravenhorst J. Substandard care in immigrant versus indigenous maternal deaths in The Netherlands. BJOG 2002, 109(2):212-3.
23. Heringa MP, Wouters MG, Vreeling HJ, Schürer G. Rapport pilotstudie BOS-GBS. 2006, Utrecht.
24. Wüst MD, Wouters MG, Schürer G, Vreeling HJ, Heringa MP. Het BOS-GBS project: een nieuwe vorm van gebruik en evaluatie van een NVOG-richtlijn. 2006, Posterpresentatie Gynaecongres. Nijmegen.
25. Woolf SH, Grol R, Hutchinson A, Eccles M, Grimshaw J. Potential benefits, limitations, and arms of clinical guidelines. BMJ 1999, 318:527-30. 1114973, 10024268.